Search Within

David Hyman

  1. "Helen Won"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (7)
  3. Research Letter (1)
Groups
  1. Department of Medicine (22)
  2. Early Drug Development Service (22)
  3. Solid Tumor Oncology Division (22)
  4. GSK Faculty (18)
  5. Hematology-Oncology Fellows (18)
  6. Human Oncology and Pathogenesis Program (18)

More Groups

People
  1. Helen Won (22)
  2. Michael Berger (15)
  3. Alison Schram (11)
  4. David Solit (11)
  5. Maurizio Scaltriti (11)
  6. Alexander Drilon (9)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2020 (5)
  4. 2019 (5)
  5. 2018 (5)
  6. 2017 (3)

More Years

Publications
  1. Cancer Research (5)
  2. Clinical Cancer Research (3)
  3. Cancer Discovery (2)
  4. Journal of Clinical Oncology (2)
  5. Nature Medicine (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. Nature Publishing Group (4)
  3. American Society of Clinical Oncology (2)
  4. American Association for the Advancement of Science (1)
  5. Cell Press (1)
  6. Oncology Nursing Society (ONS) (1)

More Publishers

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A bioinformatics framework for high-sensitivity detection and monitoring of oncogenic gene fusions in plasma cfDNA
    Meeting Abstract

    Patel, J.; Hasan, M.; Meng, F.; Jing, X.; Tam, G.; Johnson, I.; Zheng, Y.; Bandlamudi, C.; Stewart, C.; Won, H.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAPK pathway activation
    Research Letter

    Cocco, E.; Schram, A. M.; Kulick, A.; Misale, S.; Won, H. H.; Yaeger, R.; Razavi, P.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low tumor mutation burden
    Journal Article

    Benayed, R.; Offin, M.; Mullaney, K.; Sukhadia, P.; Rios, K.; Desmeules, P.; Ptashkin, R.; Won, H.; Chang, J.; Halpenny, D.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Rates of ERBB2 alterations across melanoma subtypes and a complete response to trastuzumab emtansine in an ERBB2-amplified acral melanoma
    Journal Article

    Gottesdiener, L. S.; O'Connor, S.; Busam, K. J.; Won, H.; Solit, D. B.; Hyman, D. M.; Shoushtari, A. N.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Widespread selection for oncogenic mutant allele imbalance in cancer
    Journal Article

    Bielski, C. M.; Donoghue, M. T. A.; Gadiya, M.; Hanrahan, A. J.; Won, H. H.; Chang, M. T.; Jonsson, P.; Penson, A. V.; Gorelick, A.; Harris, C.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)
    Journal Article

    Cocco, E.; Carmona, F. J.; Razavi, P.; Won, H. H.; Cai, Y.; Rossi, V.; Chan, C.; Cownie, J.; Soong, J.; Toska, E.; more...
    Science Signaling (2018)

    Fulltext@MSK | Save
  • HER kinase inhibition in patients with HER2-and HER3-mutant cancers
    Journal Article

    Hyman, D. M.; Piha-Paul, S. A.; Won, H.; Rodon, J.; Saura, C.; Shapiro, G. I.; Juric, D.; Quinn, D. I.; Moreno, V.; Doger, B.; more...
    Nature (2018)

    Fulltext@MSK | Save
  • Clinical and molecular characterization of patients with cancer of unknown primary in the modern era
    Journal Article

    Varghese, A. M.; Arora, A.; Capanu, M.; Camacho, N.; Won, H. H.; Zehir, A.; Gao, J.; Chakravarty, D.; Schultz, N.; Klimstra, D. S.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save